Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

Investors Video and Audio

The content of all investor relations materials contained on this website are deemed to be correct at the time of issue/publication.


Shield Therapeutics (LON:STX) Presenting at the Proactive One2One Virtual Forum

Apr 2021 - 38:01

SHIELD THERAPEUTICS PLC – Investor Presentation 9th March 2021

Mar 2021 - 1:02:09

Tim Watts, CEO updates on US commercialisation plans

Mar 2021 - 53:12

Shield Therapeutics raise £25m to launch Accrufer in US

Mar 2021 - 7:04

Tim Watts, CEO of Shield Therapeutics underlines some of the highlights in a business and trading update

Jan 2021 - 12:45

Shield Therapeutics remain optimistic about US commercialisation of Accrufer in the US

Jan 2021 - 14:36

Tim Watts, CEO provides an investor update on recent progress and future plans.

Dec 2020 - 1:23:20

Shield Therapeutics update on U.S. Commercialisation

Dec 2020 - 11:14

Shield Therapeutics’ cash position ‘good extension of runway to US commercialisation’ of Accrufer

Dec 2020 - 10:50

Tim Watts, CEO of Shield Therapeutics discusses their Interim Results

Sep 2020 - 11:34

Shield Therapeutics makes a profit and is ‘cash positive’ during first-half of the year

Sep 2020 - 8:01

Tim Watts, CEO of Shield Therapeutics #STX explains the headline results from the reanalysis of the study on it’s lead product

Aug 2020 - 16:07